Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
D 11.240 1.08% 0.120
BHC closed up 1.08 percent on Thursday, January 23, 2025, on 87 percent of normal volume. It ran into resistance at its 50 day moving average.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Up

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Gapped Up Strength 0.00%
50 DMA Resistance Bearish 1.08%
Crossed Above 20 DMA Bullish 1.08%
Pocket Pivot Bullish Swing Setup 1.08%
Bollinger Band Squeeze Range Contraction 1.08%
Wide Range Bar Range Expansion 1.08%
Outside Day Range Expansion 1.08%

   Recent Intraday Alerts

Alert Time
Up 3% about 11 hours ago
Rose Above 50 DMA about 15 hours ago
50 DMA Support about 15 hours ago
Gapped Up (Full) about 17 hours ago
Rose Above Previous Day's High about 17 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bausch Health Companies Inc. Description

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health S&P/Tsx 60 Index Medicine Pharma Pharmaceutical Biotechnology Pharmaceuticals Pharmaceutical Products Laser Medical Devices Atopic Dermatitis Contact Lens Psoriasis Ulcer Ulcerative Colitis Aes Dermatology Specialty Drugs Acne Actinic Keratosis Colitis Hair Removal Irritable Bowel Syndrome Keratosis Over The Counter Products

Is BHC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Comments

Indicators

Indicator Value
52 Week High 15.43
52 Week Low 5.45
Average Volume 257,116
200-Day Moving Average 10.254
50-Day Moving Average 11.282
20-Day Moving Average 11.100
10-Day Moving Average 10.933
Average True Range 0.398
RSI (14) 52.61
ADX 12.36
+DI 25.009
-DI 18.487
Chandelier Exit (Long, 3 ATRs) 10.736
Chandelier Exit (Short, 3 ATRs) 11.684
Upper Bollinger Bands 11.667
Lower Bollinger Band 10.532
Percent B (%b) 0.62
BandWidth 10.233
MACD Line -0.077
MACD Signal Line -0.095
MACD Histogram 0.0187
Fundamentals Value
Market Cap 4.13 Billion
Num Shares 368 Million
EPS -0.67
Price-to-Earnings (P/E) Ratio -16.78
Price-to-Sales 0.43
Price-to-Book 18.74
PEG Ratio 0.02
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.705
Resistance 3 (R3) 11.737 11.613 11.628
Resistance 2 (R2) 11.613 11.495 11.598 11.602
Resistance 1 (R1) 11.427 11.422 11.365 11.395 11.576
Pivot Point 11.303 11.303 11.273 11.288 11.303
Support 1 (S1) 11.117 11.185 11.055 11.085 10.904
Support 2 (S2) 10.993 11.112 10.978 10.878
Support 3 (S3) 10.807 10.993 10.853
Support 4 (S4) 10.775